WW
Wendall Wierenga (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $769K of CYTK (20,000 sh × $38.46, as filed), executed Apr 21 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$769K
shares × price, as filed
Last traded
Apr 21 2025
Filed Apr 21 2025
Median ADV $207.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $769K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
CYTKRecent filings
CYTKSALE
Cytokinetics, Incorporated
View filing →
$769K20,000 sh × $38.46
Exec Apr 21 2025
Filed Apr 21 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $233K
4,452 sh × $52.25
Exec Oct 28 2024
Filed Oct 31 2024 · 5:30 PM ET †